Status:
UNKNOWN
Hepatitis C Surveillance With Linkage to Care of Patients From Non-ID Departments in Jiangsu
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborating Sponsors:
Gilead Sciences
Conditions:
Hepatitis C, Chronic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Due to the occult nature of hepatitis C virus (HCV), it is estimated that less than 5% of people with chronic hepatitis C (CHC) infection knowing their status. The major challenges are that awareness ...
Eligibility Criteria
Inclusion
- Retrospective cohort:
- ≥ 18 years of age.
- Inpatients from non-infectious department.
- Documentation of laboratory test indicating positive HCV antibody.
- Prospective cohort:
- ≥ 18 years of age.
- Inpatients from non-infectious departments.
- Patients who meet the requirement of HCV antibody screening:
- patients with high risk possibility of HCV infection.
- patients who will have special or invasive medical operation.
- patients with unexplained abnormal liver biochemical laboratory results.
Exclusion
- Retrospective cohort: Duplicated subjects.
- Prospective cohort：Inability or unwillingness to provide informed consent or abide by the requirements of the study.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT03772002
Start Date
January 1 2019
End Date
December 31 2020
Last Update
December 13 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Third Hospital of Changzhou
Changzhou, Jiangsu, China, 213001
2
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China, 210008